Gossamer Bio, Inc.
Pharmaceutical company · San Diego, California, United States · Nasdaq: GOSS
Gossamer Bio, Inc. is a pharmaceutical company headquartered in San Diego, California, United States. Its earliest recorded incorporation is in 2015. Its shares trade on Nasdaq under the ticker GOSS. It has reported private securities offerings to the US SEC, most recently $212 million sold in a notice filed in 2023.
Gossamer Bio at a glance
What does Gossamer Bio do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $212.1 million sold (2023).
Frequently asked questions about Gossamer Bio
Where is Gossamer Bio headquartered?
Gossamer Bio, Inc. is headquartered in San Diego, California, United States.
What does Gossamer Bio do?
Gossamer Bio, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Gossamer Bio a public company?
Yes. Gossamer Bio, Inc. trades on Nasdaq under the ticker GOSS.
When was Gossamer Bio founded?
The earliest incorporation on record for Gossamer Bio, Inc. is in 2015, according to public company registers.
Similar companies
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Oncternal Therapeutics, Inc.San Diego, California, United States
- Acadia Pharmaceuticals IncSan Diego, California, United States
- ViaCyte Inc.San Diego, California, United States
- Avidity Biosciences, Inc.San Diego, California, United States
- Ligand Pharmaceuticals IncSan Diego, California, United States
- Arena Pharmaceuticals IncSan Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences